おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Selecta Biosciences
company
About
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
- 51 - 100
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3M
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.It was founded in 2008 and is headquartered in Watertown, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$76M
Selecta Biosciences has raised a total of
$76M
in funding over 2 rounds. Their latest funding was raised on
Sep 8, 2015 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 8, 2015 | Series E | $38M | 2 | — | — | Detail |
| Oct 15, 2014 | Private Equity（PE） | $20M | 2 | — | — | Detail |
| Aug 17, 2010 | Grant | $3M | 1 | — | — | Detail |
| Apr 5, 2010 | Series C | $15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Selecta Biosciences is funded by 3 investors.
Leukon Investments
and Eminent Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Leukon Investments
|
— | Series E |
|
|
— | Series E |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
